1月9日 - ** 医疗设备制造商HaemoneticsHAE.N股价下跌1.7%至84.04美元
** 公司称已收购总部位于爱尔兰的Vivasure Medical公司，交易价值高达1.85亿欧元(2.15亿美元)
** 公司表示将支付1亿欧元的预付款，并在完成某些里程碑后最高达8500万欧元。
** 总部位于爱尔兰的 Vivasure Medical 公司生产心脏和血管手术后使用的血管闭合器 - HAE
** Vivasure 的 "PerQseal Elite "贴片无需缝合即可封闭血管；已在欧洲获得批准，正在等待美国的批准 - HAE
** 公司称交易旨在扩大其医院产品组合并提升市场领导地位
** 截至上次收盘，股价在过去一年中上涨了 ~3%
(1美元 = 0.8591 欧元)
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.